AIM ImmunoTech Inc. (AIMID)
OTCMKTS
· Delayed Price · Currency is USD
6.70
-1.68 (-20.05%)
At close: Jun 13, 2025
AIM ImmunoTech Employees
As of December 31, 2024, AIM ImmunoTech had 23 total employees, including 21 full-time and 2 part-time employees. The number of employees decreased by 5 or -17.86% compared to the previous year.
Employees
23
Change (1Y)
-5
Growth (1Y)
-17.86%
Revenue / Employee
$6,636
Profits / Employee
-$691,273
Market Cap
5.96M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Federal National Mortgage Association | 8,200 |
Federal Home Loan Mortgage | 8,103 |
Jingbo Technology | 138 |
Wilson Bank Holding Company | 596 |
Apple iSports Group | 6 |
Endo Inc. | 3,116 |
AIM ImmunoTech News
- 2 days ago - AIM ImmunoTech Granted U.S. Patent Covering Methods of Manufacturing Therapeutic dsRNA, Including Ampligen® - GlobeNewsWire
- 2 days ago - AIM ImmunoTech Announces NYSE American Removal of Trading Suspension - GlobeNewsWire
- 3 days ago - AIM ImmunoTech Announces 1-for-100 Reverse Stock Split - GlobeNewsWire
- 4 weeks ago - Aimia Inc. (AIMFF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - AIM ImmunoTech Announces the Presentation of Ampligen Oncology Data at the Recent Annual Meeting of the American Association of Immunologists - GlobeNewsWire
- 2 months ago - AIM ImmunoTech Announces Trading Under the Ticker AIMI on the Pink Open Market - GlobeNewsWire
- 2 months ago - AIM ImmunoTech Announces NYSE American Notice of Delisting and Appeal - GlobeNewsWire
- 2 months ago - NYSE American to Commence Delisting Proceedings Against AIM ImmunoTech Inc. (AIM) - Business Wire